GATIFLO Side Effects

5241248-6 | Hyperglycaemia
on Feb 08, 2007 Female patient from JAPAN , 62 years of age, was treated with Gatiflo (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia. Gatiflo dosage: . Patient was hospitalized.

5241216-4 | Rhabdomyolysis
Patient was taking Gatiflo (View Usage). Patient had the following side effects: rhabdomyolysis on Feb 07, 2007 from JAPAN Additional patient health information: Male patient , 38 years of age, was diagnosed with laryngopharyngitis and. Gatiflo dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), EMPYNASE (View Empynase Review and Empynase Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), HERBAL MIXTURE (View Herbal Mixture Review and Herbal Mixture Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), BROCIN (View Brocin Review and Brocin Label ). Patient was hospitalized.

5153339-9 | Rhabdomyolysis
Adverse event was reported on Oct 21, 2006 by a Male patient taking Gatiflo (View Usage) (Dosage: ) was diagnosed with laryngopharyngitis and. Location: JAPAN , 38 years of age, After Gatiflo was administered, patient had the following side effects: rhabdomyolysis. During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), EMPYNASE (View Empynase Review and Empynase Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), HERBAL MIXTURE (View Herbal Mixture Review and Herbal Mixture Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), BROCIN (View Brocin Review and Brocin Label ). Patient was hospitalized.

5143649-3 | Hypoglycaemia
on Oct 26, 2006 Male patient from JAPAN , 82 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Gatiflo (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Gatiflo dosage: . During the same period patient was treated with RYTHMODAN R (View Rythmodan R Review and Rythmodan R Label ), NITOROL (View Nitorol Review and Nitorol Label ), GASTER D (View Gaster D Review and Gaster D Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ENSURE (View Ensure Review and Ensure Label ), BLOPRESS (View Blopress Review and Blopress Label ).


5141333-3 | Rhabdomyolysis
on Oct 21, 2006 Male patient from JAPAN , 38 years of age, was diagnosed with laryngopharyngitis and was treated with Gatiflo (View Usage). Patient had the following side effects: rhabdomyolysis. Gatiflo dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), EMPYNASE (View Empynase Review and Empynase Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ). Patient was hospitalized.

5129931-4 | Liver Disorder, Stevens-johnson Syndrome
Patient was taking Gatiflo (View Usage). After Gatiflo was administered, patient had the following side effects: liver disorder, stevens-johnson syndrome on Sep 13, 2006 from JAPAN Additional patient health information: Female patient , 27 years of age, was diagnosed with pyrexia and. Gatiflo dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

5114270-8 | Hypoglycaemia
Adverse event was reported on Sep 15, 2006 by a Female patient taking Gatiflo (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: JAPAN , 94 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia. During the same period patient was treated with CORINAEL L (View Corinael L Review and Corinael L Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ).

5108253-1 | Hypoglycaemia
on Sep 08, 2006 Female patient from JAPAN , 75 years of age, was diagnosed with cystitis and was treated with Gatiflo (View Usage). Patient had the following side effects: hypoglycaemia. Gatiflo dosage: . During the same period patient was treated with SOLETON (View Soleton Review and Soleton Label ), PAMILCON (View Pamilcon Review and Pamilcon Label ), BEHYD (View Behyd Review and Behyd Label ), NIKORANMART (View Nikoranmart Review and Nikoranmart Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLYCYRRHIZA (View Glycyrrhiza Review and Glycyrrhiza Label ).

5106829-9 | Hypoglycaemia
on Sep 06, 2006 Male patient from JAPAN , 82 years of age, was diagnosed with lung infection and was treated with Gatiflo (View Usage). After Gatiflo was administered, patient had the following side effects: hypoglycaemia. Gatiflo dosage: . During the same period patient was treated with RYTHMODAN R (View Rythmodan R Review and Rythmodan R Label ), NITOROL (View Nitorol Review and Nitorol Label ), BLOPRESS (View Blopress Review and Blopress Label ), GASTER D (View Gaster D Review and Gaster D Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

4903134-8 | Hypoglycaemia
Patient was taking Gatiflo (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Jan 27, 2006 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with cystitis and. Gatiflo dosage: Taken 10-apr-2004 To 14-apr-2004, And Again 27-apr-2004 To 28-apr-2004. During the same period patient was treated with EBRANTIL (View Ebrantil Review and Ebrantil Label ), OMEPRAL (View Omepral Review and Omepral Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), YOUFENAC (View Youfenac Review and Youfenac Label ), BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label ), NIFESLOW (View Nifeslow Review and Nifeslow Label ), LARILUDON (View Lariludon Review and Lariludon Label ). Patient was hospitalized.

4848703-9 | Interstitial Lung Disease, Liver Disorder
Adverse event was reported on Nov 28, 2005 by a Male patient taking Gatiflo (View Usage) (Dosage: ) . Location: JAPAN , 58 years of age, Patient had the following side effects: interstitial lung disease, liver disorder.

4801805-5 | C-reactive Protein Increased, Dementia, Depressed Level Of Consciousness
on Aug 18, 2005 Male patient from JAPAN , 62 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Gatiflo (View Usage). After Gatiflo was administered, patient had the following side effects: c-reactive protein increased, dementia (What is dementia?), depressed level of consciousness. Gatiflo dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MARZULENE S (View Marzulene-s Review and Marzulene-s Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), SELBEX (View Selbex Review and Selbex Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), PURSENNID (View Pursennid Review and Pursennid Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

4791784-1 | Abnormal Behaviour, C-reactive Protein Increased, Dementia, Depressed Level Of Consciousness, Disorientation, Haemodialysis, Infection, Renal Failure
on Aug 18, 2005 Male patient from JAPAN , 62 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Gatiflo (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, c-reactive protein increased, dementia (What is dementia?), depressed level of consciousness, disorientation, haemodialysis, infection (What is infection?), renal failure. Gatiflo dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MARZULENE S (View Marzulene-s Review and Marzulene-s Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), SELBEX (View Selbex Review and Selbex Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), PURSENNID (View Pursennid Review and Pursennid Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

4755946-1 | Dementia, Depressed Level Of Consciousness
Patient was taking Gatiflo (View Usage). Patient had the following side effects: dementia (What is dementia?), depressed level of consciousness on Aug 18, 2005 from JAPAN Additional patient health information: Male patient , 62 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Gatiflo dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MARZULENE S (View Marzulene-s Review and Marzulene-s Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), SELBEX (View Selbex Review and Selbex Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), PURSENNID (View Pursennid Review and Pursennid Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

4736444-8 | Cerebral Infarction, Convulsion, Depressed Level Of Consciousness
Adverse event was reported on Jul 27, 2005 by a Female patient taking Gatiflo (View Usage) (Dosage: ) was diagnosed with cystitis and. Location: JAPAN , 96 years of age, After Gatiflo was administered, patient had the following side effects: cerebral infarction, convulsion, depressed level of consciousness. During the same period patient was treated with FLOMOX (View Flomox Review and Flomox Label ), CRAVIT (View Cravit Review and Cravit Label ), LUPRAC (View Luprac Review and Luprac Label ), HALFDIGOXIN (View Halfdigoxin Review and Halfdigoxin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), UBIDECARENONE (View Ubidecarenone Review and Ubidecarenone Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ATELEC (View Atelec Review and Atelec Label ). Patient was hospitalized.